The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Open accessAbstract
Abeta1-42 is a self-associating peptide whose neurotoxic derivatives are thought to play a role in Alzheimer's pathogenesis. Neurotoxicity of amyloid beta protein (Abeta) has been attributed to its fibrillar forms, but experiments presented here characterize neurotoxins that assemble when fibril formation is inhibited. These neurotoxins comprise small diffusible Abeta oligomers (referred to as ADDLs, for Abeta-derived diffusible ligands), which were found to kill mature neurons in organotypic central nervous system cultures at nanomolar concentrations. At cell surfaces, ADDLs bound to trypsin-sensitive sites and surface-derived tryptic peptides blocked binding and afforded neuroprotection. Germ-line knockout of Fyn, a protein tyrosine kinase linked to apoptosis and elevated in Alzheimer's disease, also was neuroprotective. Remarkably, neurological dysfunction evoked by ADDLs occurred well in advance of cellular degeneration. Without lag, and despite retention of evoked action potentials, ADDLs inhibited hippocampal long-term potentiation, indicating an immediate impact on signal transduction. We hypothesize that impaired synaptic plasticity and associated memory dysfunction during early stage Alzheimer's disease and severe cellular degeneration and dementia during end stage could be caused by the biphasic impact of Abeta-derived diffusible ligands acting upon particular neural signal transduction pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, recent in vivo studies have shown that soluble Aβ oligomers are more neurotoxic than amyloid plaques and most likely responsible for synaptic dysfunction and memory loss in AD.7–11”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [10]
In the citing paper
“However, recent in vivo studies have shown that the soluble Aβ oligomers are possibly more neurotoxic than amyloid plaques,14–17 and are likely responsible for synaptic dysfunction and memory loss in AD patients and AD animal models.18–21”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [14]
In the citing paper
“recent studies have shown that the soluble Aβ oligomers are more neurotoxic both in vitro and in vivo.5−8”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [7]
In the citing paper
“For the preformed Aβ42 fibrils, no significant cell toxicity was observed in either the absence or presence of Cu2+ (Figure 9, lanes 1 and 2), supporting the previously reported diminished toxicity of Aβ42 fibrils.5,7,54−56”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [7]
In the citing paper
“This function may be critical in controlling Aβ deposition as well as levels of potentially neurotoxic Aβ oligomers (Lambert et al., 1998).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Lambert et al., 1998
In the citing paper
“While Aβ disrupts synaptic transmission 32,34,35 and induces synapse loss 17”
From NAD+ hydrolase Sarm1 is a key driver of synapse degeneration and memory loss in Alzheimer’s disease (2025) · cites this paper as [34]
In the citing paper
“In vitro, apoE and apoJ form stable complexes with A (11, 16 -20), alter the aggregation of various A peptides (21)(22)(23), and affect A neurotoxicity (24 -27).”
From Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures (2000) · cites this paper as [27]
In the citing paper
“A 1-42 aged according to this protocol is a mixture of fibrils and soluble globular aggregates, and is active to astrocytes (37,38) and toxic to neurons (26,27).”
From Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures (2000) · cites this paper as [27]
In the citing paper
“ApoJ has been shown to potentiate the formation of a neurotoxic species of A (26,27).”
From Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures (2000) · cites this paper as [27]
In the citing paper
“ApoE, apoJ, and most recently ␣ 2 -macroglobulin have been shown to form a complex with A that may facilitate clearance of the peptide (25-27, 50, 51).”
From Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures (2000) · cites this paper as [27]
In the citing paper
“Evidence suggests that increased uptake of these neurotoxic Aβ42 peptides results in accumulation and aggregation within neurons eventually leading the formation of plaques and neuronal death [40, 41].”
From The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates (2020) · cites this paper as [41]
In the citing paper
“Most importantly, these amyloid-free Aβ oligomers were potent CNS neurotoxins.”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Lambert et al., 1998
In the citing paper
“With chronic exposure, neurons ultimately were killed. Death was selective for subpopulations of vulnerable neurons and was prevented by knockout of Fyn, a protein tyrosine kinase linked to NMDA receptor signaling.”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Lambert et al., 1998
In the citing paper
“Investigation into the action of clusterin by Lambert, Klein and colleagues established that, concomitant with inhibition of amyloid formation, clusterin promotes accumulation of soluble Aβ oligomers (Lambert et al., 1998).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Lambert et al., 1998
In the citing paper
“oligomers were found to inhibit functional synaptic plasticity (Lambert et al., 1998). Long-term potentiation (LTP) was inhibited within minutes. This rapid loss of LTP, measured in rat brain slices and in situ in mice, occurred without impact on baseline excitability, indicating impairment of signaling rather than degeneration.”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Lambert et al., 1998
In the citing paper
“In hippocampal slices, synthetic oligomers cause rapid LTP inhibition (Barghorn et al., 2005; Fa et al., 2010; Jurgensen et al., 2011; Lambert et al., 1998; Nimmrich et al., 2008; Rammes et al., 2011; Wang et al., 2002).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Lambert et al., 1998
In the citing paper
“early studies showed that binding is lost upon controlled trypsin treatment of neurons (Lambert et al., 1998).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Lambert et al., 1998
In the citing paper
“In vitro and in vivo studies have now indicated that soluble Aβ oligomers impair synaptic plasticity, inhibiting hippocampal long-term potentiation (LTP), the electrophysiological correlate of learning and memory (3 –6).”
From Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein (2010) · cites this paper as [3]
Citations
Cites
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M. S., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,996
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
A simple method for organotypic cultures of nervous tissue
Stoppini, L., Buchs, P., & Muller, D. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90128-m · Cited by 3,096
Integrins and Signal Transduction Pathways: the Road Taken
Clark, E. A., & Brugge, J. S. (1995) · Science · doi:10.1126/science.7716514 · Cited by 2,911
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Research works printed but not linked: 2
- B Leveugle, A Scanameo, W Ding, H Fillit NeuroReport 5, 1389–1392 (1994).
- 10.1146/annurev.bi.63.070194.003125 · DOI
Cited by
Sorted by citations
Items 901–1,000 of 1,060
Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis
Sheppard, O., & Coleman, M. P. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch1 · Cited by 127
Walker, L. C., & LeVine, H. (2000) · Molecular Neurobiology · doi:10.1385/mn:21:1-2:083 · Cited by 105
The unsolved relationship of brain aging and late-onset Alzheimer disease
Kern, A., & Behl, C. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.016 · Cited by 108
Choucair, A., Chakrapani, M., Chakravarthy, B., Katsaras, J., & Johnston, L. J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.005 · Cited by 105
Yu, F., Zhang, Y., & Chuang, D. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2012.2449 · Cited by 110
Nilselid, A.-M., Davidsson, P., Nägga, K., Andreasen, N., Fredman, P., & Blennow, K. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.005 · Cited by 104
Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer’s disease
Gabrielli, M., Prada, I., Joshi, P., Falcicchia, C., D’Arrigo, G., Rutigliano, G., Battocchio, E., Zenatelli, R., Tozzi, F., Radeghieri, A., et al. (2022) · Brain · doi:10.1093/brain/awac083 · Cited by 106
Stefani, M., & Rigacci, S. (2014) · BioFactors · doi:10.1002/biof.1171 · Cited by 106
Hertz, L., Chen, Y., & Waagepetersen, H. S. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13107 · Cited by 103
APP Function and Lipids: A Bidirectional Link
Grimm, M. O. W., Mett, J., Grimm, H. S., & Hartmann, T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00063 · Cited by 104
Amyloid β synaptotoxicity is Wnt‐PCP dependent and blocked by fasudil
Sellers, K. J., Elliott, C., Jackson, J. D., Ghosh, A., Ribé, E. M., Rojo, A. I., Jarosz-Griffiths, H., Watson, I. A., Xia, W., Semënov, M. V., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.09.008 · Cited by 103
Nanoscale Dynamics of Amyloid β-42 Oligomers As Revealed by High-Speed Atomic Force Microscopy
Banerjee, S., Sun, Z., Hayden, E. Y., Teplow, D. B., & Lyubchenko, Y. L. (2017) · ACS Nano · doi:10.1021/acsnano.7b05434 · Cited by 106
Inhibition of Bax protects neuronal cells from oligomeric Aβ neurotoxicity
Kudo, W., Hp, L., Smith, M. A., Zhu, X., Matsuyama, S., & Lee, H.-G. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.43 · Cited by 105
Rezaei, H., Eghiaian, F., Pérez, J., Doublet, B., Choiset, Y., Haertlé, T., & Grosclaude, J. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.01.043 · Cited by 101
Evidence for Early Cytotoxic Aggregates in Transgenic Mice for Human Transthyretin Leu55Pro
Sousa, M. M., Fernandes, R., Palha, J. A., Taboada, A., Vieira, P., & Saraiva, M. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64469-0 · Cited by 108
Lee, S., Fernández, E., & Good, T. A. (2007) · Protein Science · doi:10.1110/ps.062514807 · Cited by 104
Abad, M. A., Enguita, M., DeGregorio-Rocasolano, N., Ferrer, I., & Trullas, R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0575-06.2006 · Cited by 102
Identification of Low Molecular Weight Pyroglutamate Aβ Oligomers in Alzheimer Disease
Wirths, O., Erck, C., Martens, H., Harmeier, A., Geumann, C., Jawhar, S., Kumar, S., Multhaup, G., Walter, J., Ingelsson, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178707 · Cited by 103
Li, H., Liu, C.-C., Zheng, H., & Huang, T. Y. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0139-3 · Cited by 103
Washington, P. M., Morffy, N., Parsadanian, M., Zapple, D. N., & Burns, M. P. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3017 · Cited by 103
Guerrero‐Munoz, M. J., Castillo‐Carranza, D. L., & Kayed, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.023 · Cited by 105
Fani, G., Mannini, B., Vecchi, G., Cascella, R., Cecchi, C., Dobson, C. M., Vendruscolo, M., & Chiti, F. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00811 · Cited by 106
Amyloid β peptide adversely affects spine number and motility in hippocampal neurons
Shrestha, B. R., Vitolo, O. V., Joshi, P., Lordkipanidze, T. G., Shelanski, M. L., & Dunaevsky, A. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.07.011 · Cited by 106
Tarus, B., Straub, J. E., & Thirumalai, D. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.11.022 · Cited by 102
Iulita, M. F., Allard, S. T. M., Richter, L., Munter, L. M., Ducatenzeiler, A., Weise, C., Carmo, S. D., Klein, W. L., Multhaup, G., & Cuello, A. C. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-61 · Cited by 106
Self-citationGenetics of cerebral amyloid angiopathy: systematic review and meta-analysis
Rannikmäe, K., Samarasekera, N., Martínez-González, N. A., Salman, R. A., & Sudlow, C. L. M. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303898 · Cited by 106
Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures
LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., & Van Eldik, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000602200 · Cited by 103
Mechanisms of neuronal death in disease: defining the models and the players
Ribé, E. M., Serrano‐Saiz, E., Akpan, N., & Troy, C. M. (2008) · Biochemical Journal · doi:10.1042/bj20081118 · Cited by 107
Izzo, N. J., Yuede, C. M., LaBarbera, K. M., Limegrover, C. S., Rehak, C., Yurko, R., Waybright, L., Look, G., Rishton, G., Safferstein, H., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12302 · Cited by 95
Gorman, P. M., Yip, C. M., Fraser, P. E., & Chakrabartty, A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01279-2 · Cited by 100
Choi, Y. J., Chae, S., Kim, J. H., Barald, K. F., Park, J. Y., & Lee, S. (2013) · Scientific Reports · doi:10.1038/srep01921 · Cited by 102
Subasinghe, S., Unabia, S. E., Barrow, C. J., Mok, S. S., Aguilar, M., & Small, D. H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01552.x · Cited by 104
Dolev, I., & Michaelson, D. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404458101 · Cited by 102
Perineuronal nets protect against amyloid β-protein neurotoxicity in cultured cortical neurons
Miyata, S., Nishimura, Y., & Nakashima, T. (2007) · Brain Research · doi:10.1016/j.brainres.2007.02.066 · Cited by 101
α-Synuclein Oligomers: an Amyloid Pore?
Stöckl, M. T., Zijlstra, N., & Subramaniam, V. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8331-4 · Cited by 101
The conjugation of amyloid beta protein on the gold colloidal nanoparticles’ surfaces
Yokoyama, K., & Welchons, D. R. (2007) · Nanotechnology · doi:10.1088/0957-4484/18/10/105101 · Cited by 100
Multhaup, G., Huber, O., Buée, L., & Galas, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.677211 · Cited by 101
Synaptic degeneration and neurogranin in the pathophysiology of Alzheimer’s disease
Lista, S., & Hampel, H. J. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1204234 · Cited by 103
Bourgault, S., Solomon, J. P., Reixach, N., & Kelly, J. W. (2010) · Biochemistry · doi:10.1021/bi101822y · Cited by 103
Zhang, B., Dong, Y., Zhang, G., Moir, R. D., Xia, W., Yue, Y., Tian, M., Culley, D. J., Crosby, G. J., Tanzi, R. E., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800199200 · Cited by 101
Chebaro, Y., Mousseau, N., & Derreumaux, P. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp900425e · Cited by 101
Alzheimer’s disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory
Klyubin, I. V., Cullen, W. K., Hu, N., & Rowan, M. J. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-25 · Cited by 105
Ciccotosto, G. D., Tew, D. J., Curtain, C. C., Smith, D., Carrington, D., Masters, C. L., Bush, A. I., Cherny, R. A., Cappai, R., & Barnham, K. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406465200 · Cited by 101
Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
Moreth, J., Mavoungou, C., & Schindowski, K. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-18 · Cited by 103
Stamford, A. W., Scott, J. D., Li, S. W., Babu, S., Tadesse, D., Hunter, R., Wu, Y., Misiaszek, J., Cumming, J. N., Gilbert, E. J., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml3001165 · Cited by 100
Younan, N. D., Sarell, C. J., Davies, P., Brown, D. R., & Viles, J. H. (2013) · The FASEB Journal · doi:10.1096/fj.12-222588 · Cited by 104
An Account of Amyloid Oligomers: Facts and Figures Obtained from Experiments and Simulations
Nagel‐Steger, L., Owen, M. C., & Strodel, B. (2016) · ChemBioChem · doi:10.1002/cbic.201500623 · Cited by 103
Miyamoto, T., Stein, L. R., Thomas, R., Djukic, B., Taneja, P., Knox, J. A., Vossel, K. A., & Mucke, L. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0176-x · Cited by 106
Origin of metastable oligomers and their effects on amyloid fibril self-assembly
Hasecke, F., Miti, T., Perez, C., Barton, J., Schölzel, D., Gremer, L., Grüning, C. S. R., Matthews, G., Meisl, G., Knowles, T. P. J., et al. (2018) · Chemical Science · doi:10.1039/c8sc01479e · Cited by 103
Ginkgolides protect against amyloid-β1–42-mediated synapse damage in vitro
Bate, C., Tayebi, M., & Williams, A. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-1 · Cited by 99
Structures of the Amyloid β-Peptides Aβ1–40 and Aβ1–42 as Influenced by pH and a d -Peptide
Olubiyi, O. O., & Strodel, B. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp2076337 · Cited by 100
Inhibition of Alzheimer Amyloid Aggregation with Sulfated Glycopolymers
Miura, Y., Yasuda, K., Yamamoto, K., Koike, M., Nishida, Y., & Kobayashi, K. (2007) · Biomacromolecules · doi:10.1021/bm0701402 · Cited by 100
Wang, Y., Wang, X., Lu, J.-J., Li, Q., Gao, C., Liu, X.-H., Sun, Y., Yang, M., Lim, Y. P., Evin, G. M., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2733-10.2011 · Cited by 99
Amyloid‐β oligomers are inefficiently measured by enzyme‐linked immunosorbent assay
Stenh, C., Englund, H., Lord, A., Johansson, A., Almeida, C. G., Gellerfors, P., Greengard, P., Gouras, G. K., Lannfelt, L., & Nilsson, L. N. G. (2005) · Annals of Neurology · doi:10.1002/ana.20524 · Cited by 99
Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics
Kovács, G. G., Botond, G., & Budka, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0658-1 · Cited by 102
Otzen, D. E. (2010) · Prion · doi:10.4161/pri.4.4.13676 · Cited by 102
Cheng, Y., Wang, C., Lin, H.-B., Li, Y., Huang, Y., Xu, J., & Zhang, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1943-3 · Cited by 99
Welzel, A. T., Maggio, J. E., Shankar, G. M., Walker, D., Ostaszewski, B. L., Li, S., Klyubin, I. V., Rowan, M. J., Seubert, P. A., Walsh, D. M., et al. (2014) · Biochemistry · doi:10.1021/bi5003053 · Cited by 102
Ryan, D. A., Narrow, W. C., Federoff, H. J., & Bowers, W. J. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.05.001 · Cited by 102
Fukuchi, K.-I., Tahara, K., Kim, H., Maxwell, J. A., Lewis, T. L., Accavitti-Loper, M. A., Kim, H., Ponnazhagan, S., & Lalonde, R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.012 · Cited by 100
Aβ40 Protects Non-toxic Aβ42 Monomer from Aggregation
Yan, Y., & Wang, C. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.04.014 · Cited by 99
Dinamarca, M. C., Ríos, J. A., & Inestrosa, N. C. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00464 · Cited by 105
Li, X., & Buxbaum, J. N. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-79 · Cited by 104
Best, J. D., Jay, M. T., Otu, F., Ma, J., Nadin, A. J., Ellis, S., Lewis, H. D., Pattison, C., Reilly, M., Harrison, T., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081174 · Cited by 98
Kurata, T., Miyazaki, K., Kozuki, M., Panin, V.-L., Morimoto, N., Ohta, Y., Nagai, M., Ikeda, Y., Matsuura, T., & Abe, K. (2011) · Brain Research · doi:10.1016/j.brainres.2010.11.067 · Cited by 98
Hiruma, H., Katakura, T., Takahashi, S., Ichikawa, T., & Kawakami, T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08967.2003 · Cited by 114
Impaired cell proliferation in the subventricular zone in an Alzheimer's disease model
Rodriguez, J. J., Jones, V. C., & Verkhratsky, A. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32832be77d · Cited by 101
Davis, R. C., Marsden, I. T., Maloney, M. T., Minamide, L. S., Podlisny, M. B., Selkoe, D. J., & Bamburg, J. R. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-10 · Cited by 102
Mediators of tau phosphorylation in the pathogenesis of Alzheimer’s disease
Hanger, D. P., Seereeram, A., & Noble, W. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.104 · Cited by 98
Yang, R., Zheng, Y., Wang, Q., & Zhao, L. (2018) · Nanoscale Research Letters · doi:10.1186/s11671-018-2759-z · Cited by 99
Aggregation of Disordered Proteins Associated with Neurodegeneration
Tsoi, P. S., Quan, M. D., Ferreon, J. C., & Ferreon, A. C. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043380 · Cited by 103
Delineating common molecular mechanisms in Alzheimer's and prion diseases
Barnham, K. J., Cappai, R., Beyreuther, K. T., Masters, C. L., & Hill, A. F. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.06.006 · Cited by 97
Kaczorowski, C. C., Sametsky, E. A., Shah, S., Vassar, R. J., & Disterhoft, J. F. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.09.003 · Cited by 96
Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
Mroczko, B., Groblewska, M., Litman-Zawadzka, A., Kornhuber, J., & Lewczuk, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071884 · Cited by 97
Chabrier, M. A., Cheng, D., Castello, N. A., Green, K. N., & LaFerla, F. M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.01.007 · Cited by 97
Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease
Jones, M. R., Mathieu, É., Dyrager, C., Faissner, S., Vaillancourt, Z., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., Yong, V. W., Tsutsui, S., et al. (2017) · Chemical Science · doi:10.1039/c7sc01269a · Cited by 96
Miyashita, N., Straub, J. E., & Thirumalai, D. (2009) · Journal of the American Chemical Society · doi:10.1021/ja905457d · Cited by 98
Mechanisms of amyloid plaque pathogenesis
Fiala, J. C. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0284-8 · Cited by 99
Alois Alzheimer and Alzheimer's disease: a centennial perspective
Small, D. H., & Cappai, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04212.x · Cited by 102
Detection of Polyglutamine Protein Oligomers in Cells by Fluorescence Correlation Spectroscopy
Takahashi, Y., Okamoto, Y., Popiel, H. A., Fujikake, N., Toda, T., Kinjo, M., & Nagai, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704789200 · Cited by 97
Alzheimer's disease: β‐amyloid plaque formation in human brain
Seeman, P. M., & Seeman, N. (2011) · Synapse · doi:10.1002/syn.20957 · Cited by 103
Harkany, T., Hortobágyi, T., Sasvári, M., Kónya, C., Penke, B., Luiten, P. G. M., & Nyakas, C. J. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00058-5 · Cited by 97
Imaging the pathology of Alzheimer's disease: amyloid-imaging with positron emission tomography
Klunk, W. E., Engler, H., Nordberg, A., Bacskai, B. J., Wang, Y., Price, J. C., Bergström, M., Hyman, B. T., Långström, B., & Mathis, C. A. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00092-3 · Cited by 96
Talking Point on the role of presenilin mutations in Alzheimer disease
Strooper, B. D. (2007) · Cited by 97
Aggregation and structure of amyloid β-protein
Ono, K., & Watanabe‐Nakayama, T. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105208 · Cited by 101
Proctor, D. T., Coulson, E. J., & Dodd, P. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100090 · Cited by 98
Why Alzheimer's is a disease of memory: The attack on synapses by Aß oligomers (ADDLs)
Viola, K. L., Velasco, P. T., & Klein, W. L. (2008) · The journal of nutrition health & aging · doi:10.1007/bf02982587 · Cited by 97
Self-citationAmtul, Z., Uhrig, M., Wang, L., Rozmahel, R. F., & Beyreuther, K. T. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.07.014 · Cited by 104
Suopanki, J., Götz, C., Lutsch, G., Schiller, J., Harjes, P., Herrmann, A., & Wanker, E. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03620.x · Cited by 98
A humanin derivative, S14G‐HN, prevents amyloid‐β‐induced memory impairment in mice
Tajima, H., Kawasumi, M., Chiba, T., Yamada, M., Yamashita, K., Nawa, M., Kita, Y. A., Kouyama, K., Aiso, S., Matsuoka, M., et al. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20391 · Cited by 99
Liu, R., Groen, T. V., Katre, A. K., Cao, D., Kadisha, I., Ballinger, C. A., Wang, L., Carroll, S. L., & Li, L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.06.003 · Cited by 97
A β 1-42 Induces Mild Endoplasmic Reticulum Stress in an Aggregation State–Dependent Manner
Chafekar, S. M., Hoozemans, J. J. M., Zwart, R., Baas, F., & Scheper, W. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1797 · Cited by 97
Aβ Oligomers Induce Glutamate Release from Hippocampal Neurons
Brito‐Moreira, J., Paula-Lima, A. C., Bomfim, T. R., de Oliveira, F. F., Sepúlveda, F. J., Mello, F. G. D., Aguayo, L. G., Panizzutti, R., & Ferreira, S. T. (2011) · Current Alzheimer Research · doi:10.2174/156720511796391917 · Cited by 111
Biphasic Effects of Insulin on Islet Amyloid Polypeptide Membrane Disruption
Brender, J., Lee, E. L., Hartman, K. L., Wong, P. T., Ramamoorthy, A., Steel, D. G., & Gafni, A. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2010.09.070 · Cited by 93
Glutamate and Mitochondria: Two Prominent Players in the Oxidative Stress-Induced Neurodegeneration
Cassano, T., Pace, L., Bedse, G., Lavecchia, A. M., Marco, F. D., Gaetani, S., & Serviddio, G. (2015) · Current Alzheimer Research · doi:10.2174/1567205013666151218132725 · Cited by 96
Salahuddin, P., Fatima, M. T., Abdelhameed, A. S., Nusrat, S., & Khan, R. H. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.065 · Cited by 101
Han, S., Kollmer, M., Markx, D., Claus, S., Walther, P., & Fändrich, M. (2017) · Scientific Reports · doi:10.1038/srep43577 · Cited by 95
Why are Functional Amyloids Non-Toxic in Humans?
Jackson, M. P., & Hewitt, E. W. (2017) · Biomolecules · doi:10.3390/biom7040071 · Cited by 98
Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer’s Disease
Toniolo, S., Sen, A., & Husain, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239318 · Cited by 97
Calsolaro, V., & Edison, P. (2015) · CNS Drugs · doi:10.1007/s40263-015-0301-8 · Cited by 93
Metadata
- Authors
- Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., & Klein, W. L.
- Affiliations
- Northwestern University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-05-26
- Volume
- 95
- Issue
- 11
- Pages
- 6448-6453
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC27787
- OpenAlex
- W2165021720
- Cited by
- 3,506
- References
- 68
- Citations by year
- 2026: 61 · 2025: 69 · 2024: 82 · 2023: 81 · 2022: 101 · 2021: 115 · 2020: 137 · 2019: 105 · 2018: 127 · 2017: 138 · 2016: 139 · 2015: 152 · 2014: 171 · 2013: 188 · 2012: 196
- FWCI
- 29.85
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid-beta 42, neurotoxicity, Alzheimer's disease, Fyn tyrosine kinase, neuroprotection, hippocampal long-term potentiation, synaptic plasticity, signal transduction, organotypic brain cultures
- MeSH terms
- Alzheimer Disease, Animals, Brain, Cell Membrane, Cells, Cultured, Ligands, Neurotoxins, Amyloid beta-Peptides, Cell Death, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
